R&D Systems™ Recombinant Mouse IL-9 (HEK293 expressed) Protein

Description

Carrier Free Recombinant Protein

Measured in a cell proliferation assay using MO7e human megakaryocytic leukemic cells. Avanzi, G. et al. (1988) Br. J. Haematol. 69:359. The ED50 for this effect is 1.50-15.0 ng/mL.

Specifications

• Accession Number: P15247.1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 3578
• Molecular Weight (g/mol): MolecularWeight-observed: 35-39 kDa, under reducing conditions., MolecularWeight-theroretical: 14 kDa
• Quantity: 10 μg
• Source: Human embryonic kidney cell, HEK293-derived mouse IL-9 protein Gln19-Pro144
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: Cytokine P40, HP40, IL9, IL-9 homolog of mouse T cell and mast cell growth factor 40, interleukin 9, interleukin-9, P40, p40 cytokine, p40 T-cell and mast cell growth factor, T-cell growth factor P40
• Conjugate: Unconjugated
• Reconstitution: Reconstitute the 10 μg size at 100 μg/mL in PBS. Reconstitute all other sizes (at 500 μg/mL in PBS.)
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: IL-9